Sequencing studies in human genetics: Design and interpretation

Nature Reviews Genetics

Volumn 14, Issue 7, 2013, Pages 460-470

  Goldstein, David B ^a   Allen, Andrew ^a,b   Keebler, Jonathan ^a   Margulies, Elliott H ^c   Petrou, Steven ^d   Petrovski, Slavé ^a,d   Sunyaev, Shamil ^e  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c Illumina Cambridge   (United Kingdom)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; CHILDHOOD DISEASE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FUNCTIONAL ASSESSMENT; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC DISORDER; GENETIC MODEL; GENETIC VARIABILITY; GENOME; GENOTYPE; HUMAN; HUMAN GENETICS; PHENOTYPE; PLURIPOTENT STEM CELL; POPULATION GENETICS; PREDICTION; PRIORITY JOURNAL; REVIEW; WORKFLOW;

ANIMALS; COMPUTER SIMULATION; GENES, DOMINANT; GENETIC DISEASES, INBORN; GENETIC LINKAGE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENETICS, POPULATION; GENOME; GENOTYPE; HUMANS; MODELS, GENETIC; MUTATION; RISK FACTORS; SEQUENCE ANALYSIS, DNA;

EID: 84879411643     PISSN: 14710056     EISSN: 14710064     Source Type: Journal    
DOI: 10.1038/nrg3455     Document Type: Review

References (87)

1. Hindorff, L. A. et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc. Natl Acad. Sci. USA 106, 9362-9367 (2009).
2. McCarthy, M. I. et al. Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nature Rev. Genet. 9, 356-369 (2008). (Pubitemid 351556063)
3. Hoggart, C. J., Clark, T. G., De Iorio, M., Whittaker, J. C. & Balding, D. J. Genome-wide significance for dense SNP and resequencing data. Genet. Epidemiol. 32, 179-185 (2008). (Pubitemid 351288034)
4. Cirulli, E. T. & Goldstein, D. B. Uncovering the roles of rare variants in common disease through whole-genome sequencing. Nature Rev. Genet. 11, 415-425 (2010).
5. Bamshad, M. J. et al. Exome sequencing as a tool for Mendelian disease gene discovery. Nature Rev. Genet. 12, 745-755 (2011).
6. Meyerson, M., Gabriel, S. & Getz, G. Advances in understanding cancer genomes through second-generation sequencing. Nature Rev. Genet. 11, 685-696 (2010).
7. Ding, L., Wendl, M. C., Koboldt, D. C. & Mardis, E. R. Analysis of next-generation genomic data in cancer: accomplishments and challenges. Hum. Mol. Genet. 19, R188-R196 (2010).
8. Shendure, J. & Ji, H. Next-generation DNA sequencing. Nature Biotech. 26, 1135-1145 (2008).
9. Ajay, S. S., Parker, S. C., Abaan, H. O., Fajardo, K. V. & Margulies, E. H. Accurate and comprehensive sequencing of personal genomes. Genome Res. 21, 1498-1505 (2011).
10. Genomes Project, C. A map of human genome variation from population-scale sequencing. Nature 467, 1061-1073 (2010).
11. Wendl, M. C. & Wilson, R. K. The theory of discovering rare variants via DNA sequencing. BMC Genomics 10, 485 (2009).
12. Need, A. C. et al. Clinical application of exome sequencing in undiagnosed genetic conditions. J. Med. Genet. 49, 353-361 (2012).
13. Heinzen, E. L. et al. Exome sequencing followed by large-scale genotyping fails to identify single rare variants of large effect in idiopathic generalized epilepsy. Am. J. Hum. Genet. 91, 293-302 (2012).
14. Need, A. C. et al. Exome sequencing followed by large-scale genotyping suggests a limited role for moderately rare risk factors of strong effect in schizophrenia. Am. J. Hum. Genet. 91, 303-312 (2012).
15. Zhu, M. et al. Using ERDS to infer copy-number variants in high-coverage genomes. Am. J. Hum. Genet. 91, 408-421 (2012).
16. Heinzen, E. L. et al. De novo mutations in ATP1A3 cause alternating hemiplegia of childhood. Nature Genet. 44, 1030-1034 (2012).
17. Li, B. et al. A likelihood-based framework for variant calling and de novo mutation detection in families. PLoS Genet. 8, e1002944 (2012).
18. Nielsen, R., Paul, J. S., Albrechtsen, A. & Song, Y. S. Genotype and SNP calling from next-generation sequencing data. Nature Rev. Genet. 12, 443-451 (2011).
19. Flicek, P. & Birney, E. Sense from sequence reads: methods for alignment and assembly. Nature Methods 6, S6-S12 (2009).
20. DePristo, M. A. et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nature Genet. 43, 491-498 (2011).
21. Lunter, G. & Goodson, M. Stampy: a statistical algorithm for sensitive and fast mapping of Illumina sequence reads. Genome Res. 21, 936-939 (2011).
22. Li, H. Improving SNP discovery by base alignment quality. Bioinformatics 27, 1157-1158 (2011).
23. Meacham, L. R. et al. Diabetes mellitus in long-term survivors of childhood cancer. Increased risk associated with radiation therapy: a report for the childhood cancer survivor study. Arch. Intern. Med. 169, 1381-1388 (2009).
24. McKenna, A. et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 20, 1297-1303 (2010).
25. Neale, B. M. et al. Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature 485, 242-245 (2012).
26. Chen, W. et al. Genotype calling and haplotyping in parent-offspring trios. Genome Res. 23, 142-151 (2013).
27. Conrad, D. F. et al. Variation in genome-wide mutation rates within and between human families. Nature Genet. 43, 712-714 (2011).
28. Alkan, C. et al. Personalized copy number and segmental duplication maps using next-generation sequencing. Nature Genet. 41, 1061-1067 (2009).
29. Hach, F. et al. mrsFAST: a cache-oblivious algorithm for short-read mapping. Nature Methods 7, 576-577 (2010).
30. Iossifov, I. et al. De novo gene disruptions in children on the autistic spectrum. Neuron 74, 285-299 (2012).
31. de Ligt, J. et al. Diagnostic exome sequencing in persons with severe intellectual disability. N. Engl. J. Med. 367, 1921-1929 (2012).
32. Rauch, A. et al. Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study. Lancet 380, 1674-1682 (2012).
33. Sanders, S. J. et al. De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature 485, 237-241 (2012).
34. O'Roak, B. J. et al. Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature 485, 246-250 (2012).
35. Danecek, P. et al. The variant call format and VCFtools. Bioinformatics 27, 2156-2158 (2011).
36. Saunders, C. J. et al. Rapid whole-genome sequencing for genetic disease diagnosis in neonatal intensive care units. Sci. Transl. Med. 4, 154ra135 2012
37. Bell, C. J. et al. Carrier testing for severe childhood recessive diseases by next-generation sequencing. Sci. Transl. Med. 3, 65ra4 (2011).
38. Kimura, M. The Neutral Theory of Molecular Evolution (Cambridge Press, 1983).
39. Sim, N. L. et al. SIFT web server: predicting effects of amino acid substitutions on proteins. Nucleic Acids Res. 40, W452-W457 (2012).
40. Adzhubei, I. A. et al. A method and server for predicting damaging missense mutations. Nature Methods 7, 248-249 (2010).
41. Stone, E. A. & Sidow, A. Physicochemical constraint violation by missense substitutions mediates impairment of protein function and disease severity. Genome Res. 15, 978-986 (2005). (Pubitemid 40994218)
42. Jordan, D. M., Ramensky, V. E. & Sunyaev, S. R. Human allelic variation: perspective from protein function, structure, and evolution. Curr. Opin. Struct. Biol. 20, 342-350 (2010).
43. Schwarz, J. M., Rodelsperger, C., Schuelke, M. & Seelow, D. MutationTaster evaluates disease-causing potential of sequence alterations. Nature Methods 7, 575-576 (2010).
44. Hicks, S., Wheeler, D. A., Plon, S. E. & Kimmel, M. Prediction of missense mutation functionality depends on both the algorithm and sequence alignment employed. Hum. Mutat. 32, 661-668 (2011).
45. Cooper, G. M. & Shendure, J. Needles in stacks of needles: finding disease-causal variants in a wealth of genomic data. Nature Rev. Genet. 12, 628-640 (2011).
46. Bustamante, C. D. et al. Natural selection on protein-coding genes in the human genome. Nature 437, 1153-1157 (2005). (Pubitemid 41509352)
47. Asthana, S. et al. Widely distributed noncoding purifying selection in the human genome. Proc. Natl Acad. Sci. USA 104, 12410-12415 (2007). (Pubitemid 47206151)
48. Stenson, P. D. et al. Human Gene Mutation Database (HGMD): 2003 update. Hum. Mutat. 21, 577-581 (2003). (Pubitemid 36667346)
49. Morgenthaler, S. & Thilly, W. G. A strategy to discover genes that carry multi-allelic or mono-allelic risk for common diseases: a cohort allelic sums test (CAST). Mutat. Res. 615, 28-56 (2007). (Pubitemid 46054081)
50. Li, B. & Leal, S. M. Methods for detecting associations with rare variants for common diseases: application to analysis of sequence data. Am. J. Hum. Genet. 83, 311-321 (2008).
51. Madsen, B. E. & Browning, S. R. A groupwise association test for rare mutations using a weighted sum statistic. PLoS Genet. 5, e1000384 (2009).
52. Price, A. L. et al. Pooled association tests for rare variants in exon-resequencing studies. Am. J. Hum. Genet. 86, 832-838 (2010).
53. Neale, B. M. et al. Testing for an unusual distribution of rare variants. PLoS Genet. 7, e1001322 (2011).
54. Wu, M. C. et al. Rare-variant association testing for sequencing data with the sequence kernel association test. Am. J. Hum. Genet. 89, 82-93 (2011).
55. Lin, D. Y. & Tang, Z. Z. A general framework for detecting disease associations with rare variants in sequencing studies. Am. J. Hum. Genet. 89, 354-367 (2011).
56. Basu, S. & Pan, W. Comparison of statistical tests for disease association with rare variants. Genet. Epidemiol. 35, 606-619 (2011).
57. Bansal, V., Libiger, O., Torkamani, A. & Schork, N. J. Statistical analysis strategies for association studies involving rare variants. Nature Rev. Genet. 11, 773-785 (2010).
58. Stitziel, N. O., Kiezun, A. & Sunyaev, S. Computational and statistical approaches to analyzing variants identified by exome sequencing. Genome Biol. 12, 227 (2011).
59. Kiezun, A. et al. Exome sequencing and the genetic basis of complex traits. Nature Genet. 44, 623-630 (2012).
60. Ladouceur, M., Dastani, Z., Aulchenko, Y. S., Greenwood, C. M. & Richards, J. B. The empirical power of rare variant association methods: results from Sanger sequencing in 1, 998 individuals. PLoS Genet. 8, e1002496 (2012).
61. Zhu, Q. et al. A genome-wide comparison of the functional properties of rare and common genetic variants in humans. Am. J. Hum. Genet. 88, 458-468 (2011).
62. Tennessen, J. A. et al. Evolution and functional impact of rare coding variation from deep sequencing of human exomes. Science 337, 64-69 (2012).
63. Harrison, P. J. & Weinberger, D. R. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol. Psychiatry 10, 40-68 (2005). (Pubitemid 40139588)
64. Prathikanti, S. & Weinberger, D. R. Psychiatric genetics- the new era: genetic research and some clinical implications. Br. Med. Bull. 73-74, 107-122 (2005). (Pubitemid 43020362)
65. Mutsuddi, M. et al. Analysis of high-resolution HapMap of DTNBP1 (Dysbindin) suggests no consistency between reported common variant associations and schizophrenia. Am. J. Hum. Genet. 79, 903-909 (2006). (Pubitemid 44763404)
66. Need, A. C. et al. A genome-wide investigation of SNPs and CNVs in schizophrenia. PLoS Genet. 5, e1000373 (2009).
67. Hoefen, R. et al. In silico cardiac risk assessment in patients with long QT syndrome: type 1: clinical predictability of cardiac models. J. Am. Coll. Cardiol 60, 2182-2191 (2012).
68. Berecki, G., Zegers, J. G., Wilders, R. & Van Ginneken, A. C. Cardiac channelopathies studied with the dynamic action potential-clamp technique. Methods Mol. Biol. 403, 233-250 (2007).
69. Zareba, W., Moss, A. J. & le Cessie, S. Dispersion of ventricular repolarization and arrhythmic cardiac death in coronary artery disease. Am. J. Cardiol. 74, 550-553 (1994). (Pubitemid 24279934)
70. Redfern, W. S. et al. Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development. Cardiovasc. Res. 58, 32-45 (2003). (Pubitemid 36351620)
71. Di Ventura, B., Lemerle, C., Michalodimitrakis, K. & Serrano, L. From in vivo to in silico biology and back. Nature 443, 527-533 (2006). (Pubitemid 44527283)
72. Reid, C. A. et al. Multiple molecular mechanisms for a single GABAA mutation in epilepsy. Neurology 80, 1003-1008 (2013).
73. Freimuth, J. et al. Epistatic interactions between Tgfb1 and genetic loci, Tgfbm2 and Tgfbm3, determine susceptibility to an asthmatic stimulus. Proc. Natl Acad. Sci. USA 109, 18042-18047 (2012).
74. Lehner, B. Genotype to phenotype: lessons from model organisms for human genetics. Nature Rev Genet. 14, 168-178 (2013).
75. Tiscornia, G., Vivas, E. L. & Izpisua Belmonte, J. C. Diseases in a dish: modeling human genetic disorders using induced pluripotent cells. Nature Med. 17, 1570-1576 (2011).
76. Overington, J. P., Al-Lazikani, B. & Hopkins, A. L. How many drug targets are there? Nature Rev. Drug Discov. 5, 993-996 (2006). (Pubitemid 44835126)
77. Consortium, E. P. et al. An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57-74 (2012).
78. Ge, D. et al. SVA: software for annotating and visualizing sequenced human genomes. Bioinformatics 27, 1998-2000 (2011).
79. Pruitt, K. D. et al. The consensus coding sequence (CCDS) project: identifying a common protein-coding gene set for the human and mouse genomes. Genome Res. 19, 1316-1323 (2009).
80. Davydov, E. V. et al. Identifying a high fraction of the human genome to be under selective constraint using GERP++. PLoS Comput. Biol. 6, e1001025 (2010).
81. Henikoff, S. & Henikoff, J. G. Amino acid substitution matrices from protein blocks. Proc. Natl Acad. Sci. USA 89, 10915-10919 (1992).
82. Choi, J. W., Kang, D. K., Park, H., deMello, A. J. & Chang, S. I. High-throughput analysis of proteinprotein interactions in picoliter-volume droplets using fluorescence polarization. Anal. Chem. 84, 3849-3854 (2012).
83. Ghosh, S., Matsuoka, Y., Asai, Y., Hsin, K. Y. & Kitano, H. Software for systems biology: from tools to integrated platforms. Nature Rev. Genet. 12, 821-832 (2011).
84. Ashcroft, F. M. From molecule to malady. Nature 440, 440-447 (2006).
85. Owens, J. Determining druggability. Nature Rev. Drug Discov. 6, 187 (2007).
86. Marth, G. T. et al. A general approach to single-nucleotide polymorphism discovery. Nature Genet. 23, 452-456 (1999).
87. Bruce, H. A. et al. Long tandem repeats as a form of genomic copy number variation: structure and length polymorphism of a chromosome 5p repeat in control and schizophrenia populations. Psychiatr. Genet. 19, 64-71 (2009).